Novo Nordisk® logo
NovoCare® Savings | Coverage | Support NovoCare® Savings | Coverage | Support
Novo Nordisk® logo

Terms and Conditions of Use

NovoCare® Pharmacy (CoAssist Pharmacy d/b/a NovoCare® Pharmacy)

Covered products

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, 2 mg

Total strength per total volume
NDC

2 mg/3 mL
0169-4181-13

4 mg/3 mL
0169-4130-13

8 mg/3 mL
0169-4772-12

Eligibility and Restrictions

To participate in this Ozempic® NovoCare® Pharmacy self-pay/cash program, patients must have a valid prescription for Ozempic®. A valid Prescriber ID# is required on the prescription. 

Patients are not eligible if they are enrolled in any federal or state health care program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a government program), or where prohibited by law.

Patients may only participate in this program if they have been prescribed Ozempic® for an FDA-approved indication within Ozempic®’s labeling. Patients may participate in this program if they are uninsured or self-pay. If the patient fulfills their prescription through this program, the transaction will be processed outside of any insurance. Patient payments will not count toward any deductibles and cannot be applied to a patient’s maximum out-of-pocket costs.

By using this program, patients certify that they meet the eligibility criteria, will comply with the terms and conditions described herein, and will not seek reimbursement for any medication received through this program.

Novo Nordisk’s Eligibility and Restrictions, and Program Details, may change from time to time, and for the most recent version, please visit this webpage. Reconfirmation of patient information may be requested periodically to ensure accuracy of data and compliance with terms. Patients with questions about the program may call 1-888-809-3942.

This offer is not insurance. This offer is not contingent on any past, current, or future purchase of Ozempic®. This offer cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer not associated with this offer. This offer is valid only in the United States and its territories, unless prohibited by law.

Program Details

NovoCare® Pharmacy operates through licensed pharmacies that dispense product under a cash/self-pay model, and insurance is not accepted. These cash/self-pay prescriptions are filled by CenterWell® Pharmacy or CoAssist Pharmacy d/b/a Novocare® Pharmacy.

When a prescription is received from a licensed prescriber, NovoCare® will review and validate the prescription. Patients with commercial insurance coverage for Ozempic® will have the option to utilize the cash program through CenterWell® Pharmacy and/or CoAssist Pharmacy d/b/a NovoCare® Pharmacy (“NovoCare® Pharmacy”), or transfer the prescription to a retail pharmacy if they choose to apply their prescription insurance to the prescription fulfillment.

Patients enrolled in this program can pay:

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, 2 mg

Self-pay offer details (effective November 17, 2025)

Total strength per volume

NDC

Price for 1 month (1 box)

Price for 2 month (2 boxes)

Price for 3 month (3 boxes)

Limited Time Offer for new patientsa: $199

Ozempic® 2 mg/3 mL

00169-4181-13

$349

$698

$1,047

Ozempic® 4 mg/3 mL

00169-4130-13

$349

$698

$1,047

Ozempic® 8 mg/3 mL

00169-4772-12

$499

$698

$1,047

Self-pay offer details
(effective November 17, 2025)

Total strength per volume
Ozempic® 2 mg/3 mL

NDC
00169-4181-13

Price for 1 month (1 box)
Limited Time Offer for new patientsa: $199
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Ozempic® 4 mg/3 mL

NDC
00169-4130-13

Price for 1 month (1 box)
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Ozempic® 8 mg/3 mL

NDC
00169-4772-12

Price for 1 month (1 box)
$499

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

aOzempic® injection 0.25 mg and 0.5 mg (2 mg/3 mL): For a limited time, patients who have not already filled a prescription for Ozempic® injection through NovoCare® Pharmacy will be eligible for a promotional offer of $199 for each monthly fill (1 box) of the Ozempic® 2 mg/3 ml injection. Offer only available for 2 monthly fills between November 17, 2025–March 31, 2026. For each fill after and for Ozempic® 4 mg/3 mL injection, you will pay $349 per 1-month prescription (1 box), $698 per 2-month prescription (2 boxes), or $1,047 per 3-month prescription (3 boxes) of Ozempic®. For Ozempic® 8 mg/3 mL, you will pay $499 per 1-month prescription (1 box), $998 per 2-month prescription (2 boxes), or $1,497 per 3-month prescription (3 boxes) of Ozempic®.

Patients are eligible for the limited-time offer so long as the prescription is received by NovoCare® Pharmacy by end of day on 3/31/2026 and shipped on or before 4/30/2026.

Assurance of Medication Supply

This program will continue to enroll patients so long as each enrolled patient can receive a consistent supply of medication. This assurance is only applicable for those patients who remain enrolled and adherent to the treatment. Novo Nordisk reserves the right to pause or terminate enrollment to prioritize supply for those qualified.

Disclosure of Third-Party Partnerships

AssistRx: A patient solutions provider responsible for NovoCare®’s access and reimbursement live support program. They manage patient intake and outreach and offer live support. 

CoAssist: A licensed pharmacy in all 50 US States and territories that for purposes of this program is CoAssist Pharmacy d/b/a NovoCare® Pharmacy. CoAssist takes in the prescription after NovoCare®’s access and reimbursement live support program reviews patient’s insurance type and benefits investigation to determine eligibility for program. Eligible patients may then have their HCP’s prescription transferred from CoAssist to CenterWell® Pharmacy, where CenterWell® further validates the prescription, and processes it for shipment to patient’s home, or CoAssist Pharmacy d/b/a NovoCare® Pharmacy may act as the dispensing pharmacy.

CenterWell®: NovoCare®’s dispensing pharmacy responsible for patient accounts, payment collection, medication fulfillment, tracking, and shipping.

NovoCare_Ozempic_v01

Important Safety Information for Ozempic®

Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

What is the most important information I should know about Ozempic®?

Ozempic® may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
  • Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is Ozempic®?

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used:

  • along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
  • to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease.
  • to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease.

It is not known if Ozempic® is safe and effective for use in children.

Important Safety Information

Do not use Ozempic® if:

  • you or any of your family have ever had MTC or if you have MEN 2.
  • you are allergic to semaglutide or any of the ingredients in Ozempic®. See symptoms of serious allergic reaction in “What are the possible side effects of Ozempic®?”.

Before using Ozempic®, tell your health care provider if you have any other medical conditions, including if you:

  • have or have had problems with your pancreas.
  • have a history of diabetic retinopathy.
  • have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation).
  • are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Ozempic® will harm your unborn baby or pass into your breast milk. You should stop using Ozempic® at least 2 months before you plan to become pregnant.

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.

What are the possible side effects of Ozempic®?

Ozempic® may cause serious side effects, including:

  • inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®.
  • low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.
  • dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away.
  • severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Ozempic®. Tell your health care provider if you have stomach problems that are severe or will not go away.
  • serious allergic reactions. Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • gallbladder problems. Gallbladder problems have happened in some people who take Ozempic®. Tell your healthcare provider right away if you get symptoms which may include: pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Ozempic® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Ozempic® before you are scheduled to have surgery or other procedures.

The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.

Please see Prescribing Information and Medication Guide for Ozempic®.

Ozempic® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.